Search Medical Condition
Please enter condition
Please choose location from dropdown

PE, Santo Amaro, Recife Clinical Trials

A listing of PE, Santo Amaro, Recife clinical trials actively recruiting patients volunteers.

RESULTS

Found (205) clinical trials

Preeclampsia is a complication of pregnancy. Preeclampsia may occur from 20 weeks’ pregnancy through the delivery and postpartum period.  Preeclampsia does not occur in every pregnant woman. It is thought that preeclampsia occurs in about 3 to 5 out of a total of 100 pregnant women. A higher number of ...

Phase N/A

NYU Winthrop Hospital Clinical Trials Center is seeking research participants who are 18 years old or older, who are pregnant and between 28 and 37 weeks gestation and are interested in participating in a clinical trial.  Participants will be asked to provide blood and urine sample(s) to be used to ...

Phase N/A

Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin

The purpose of this study is to determine if weight-based heparin infusions at a rate of 10 units/kg/hour are sufficient to maintain a target anti-Xa of 0.1-0.35 IU/mL for VTE prophylaxis in patients undergoing microvascular surgery. Additionally, a pilot protocol has been developed to titrate these heparin infusions to ensure ...

Phase N/A

Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys

The overarching purpose of SATISFY-SOS is to implement a rigorous process to assess short-term and intermediate-term outcomes of surgical and procedural patients who receive anesthesia services at Barnes-Jewish Hospital facilities, located in St. Louis, Missouri. Specifically, patients will be followed for major morbidity events, for mortality, and for quality of ...

Phase N/A

PROMOtion of VAccination in Canada (PromovaC Study)

OBJECTIVES Main objective: To evaluate the impact of the motivational interviewing (MI) intervention on parents' intention to vaccinate their infant and their vaccine hesitancy (VH) score in a Pan-Canadian context. In order to explore differences in the intervention's impact according to cultural and organizational factors, all analysis will also be ...

Phase N/A

Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma

The rates of Venous thromboembolism (VTE) after orthopedic surgery are as high as 40-60% without prophylactic measures. Enoxaparin, a low-molecular-weight heparin, produces an anticoagulant effect by binding antithrombin, thereby accelerating antithrombin's inactivation of coagulation factor Xa (FXa), thus decreasing the likelihood of clot formation. Despite standard dosing enoxaparin prophylaxis, VTE ...

Phase

Response to Anti-hypertensives in Pregnant and Postpartum Patients

Hypertensive disease in pregnancy is a major cause of maternal morbidity and mortality. This condition is responsible for about 12% of the maternal deaths in the United States. Currently, if pregnant patients present with severe hypertension they are either given IV labetalol, IV hydralazine of nifedipine based on individual provider ...

Phase

LimPrOn: Limburg Pre-eclampsia Investigation

Background Multiple adaptations at the cardiovascular system occurs during pregnancy. In the pregnancy condition pre-eclampsia (PE), this adaptations are abnormal. Five to eight percent of all pregnant women worldwide will develop PE. PE is a pregnancy condition which is characterized with a high blood pressure (>140/90 mm Hg) and the ...

Phase N/A

Pulmonary Embolism Response to Fragmentation Embolectomy & Catheter Thrombolysis: PERFECT

The primary objective of this study is to capture high quality patient safety and effectiveness data on CDT for acute PE. The goal will be achieved by capturing a concise set of immediate and short-term functional and clinical outcome data for PE patients undergoing CDT. Secondary study objectives include the ...

Phase N/A

IgG Dependent Monocyte Activation in Proximal Venous Thromboembolism

The secondary objectives of this study include to compare the IgG-dependent monocyte activation profiles as a function of laboratory thrombophilia parameters. Essentially: Is IgG-dependent cell activation associated with the presence of anti-phospholipid antibodies (or their subtypes?), or do these profiles indicate something beyond the nosology of anti-phospholipid syndrome?

Phase N/A